These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3471283)

  • 41. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
    Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infrequent microsatellite instability during the evolution of myelodysplastic syndrome to acute myelocytic leukemia.
    Tasak T; Lee S; Spira S; Takeuchi S; Hatta Y; Nagai M; Takahara J; Koeffler HP
    Leuk Res; 1996 Feb; 20(2):113-7. PubMed ID: 8628009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired auto-anti D in a patient with myelodysplastic syndrome.
    Yermiahu T; Dvilansky A; Avinoam I; Benharroch D
    Sangre (Barc); 1991 Feb; 36(1):47-9. PubMed ID: 1906640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic myeloid leukemia in lymphoid blast crisis.
    Cherian S; Walter RB
    Eur J Haematol; 2014; 92(5):458. PubMed ID: 24215714
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.
    Balleisen S; Kuendgen A; Hildebrandt B; Haas R; Germing U
    Leuk Res; 2009 Sep; 33(9):1189-93. PubMed ID: 19428106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes.
    Hirst WJ; Mufti GJ
    Leuk Res; 1994 Nov; 18(11):797-804. PubMed ID: 7967705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
    Caron PC; Dumont L; Scheinberg DA
    Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome.
    Iyer RV; Sait SN; Matsui S; Block AW; Barcos M; Slack JL; Wetzler M; Baer MR
    Cancer Genet Cytogenet; 2004 Jan; 148(1):29-34. PubMed ID: 14697638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure.
    Thepot S; Boehrer S; Seegers V; Prebet T; Beyne-Rauzy O; Wattel E; Delaunay J; Raffoux E; Hunault M; Jourdan E; Chermat F; Sebert M; Kroemer G; Fenaux P; Adès L;
    Leuk Res; 2014 Dec; 38(12):1430-4. PubMed ID: 25449687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
    Amin HM; Yang Y; Shen Y; Estey EH; Giles FJ; Pierce SA; Kantarjian HM; O'Brien SM; Jilani I; Albitar M
    Leukemia; 2005 Sep; 19(9):1567-72. PubMed ID: 16049515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.
    Voso MT; Niscola P; Piciocchi A; Fianchi L; Maurillo L; Musto P; Pagano L; Mansueto G; Criscuolo M; Aloe-Spiriti MA; Buccisano F; Venditti A; Tendas A; Piccioni AL; Zini G; Latagliata R; Filardi N; Fragasso A; Fenu S; Breccia M;
    Eur J Haematol; 2016 Apr; 96(4):344-51. PubMed ID: 26018238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Choroid infiltration in myelodysplastic syndrome].
    Madjlessi F; Dann K; Althaus C; Sundmacher R; Meckenstock G
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):51-4. PubMed ID: 9743940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double minute chromosomes in a patient with myelodysplastic syndrome transforming into acute myeloid leukemia.
    Michalová K; Cermák J; Brezinová J; Zemanová Z
    Cancer Genet Cytogenet; 1999 Feb; 109(1):76-8. PubMed ID: 9973965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two cases of acute myeloid leukemia evolving into a chronic myelomonocytic leukemia-like state after induction therapy.
    Iwama A; Miwa A; Suzuki T; Komatsu N; Yoshida M; Suda T; Sakamoto S; Miura Y
    Intern Med; 1992 Feb; 31(2):214-7. PubMed ID: 1600270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
    Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
    Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of myeloid differentiation antigens on myeloblasts in bone marrow of patients with myelodysplastic syndromes.
    Borbenyi Z; Ghosh A; Cinkotai K; Balogh E; Moore M
    Biomed Pharmacother; 1987; 41(2):101-4. PubMed ID: 3475134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. A Leukemia Intergroup Study.
    Khan SP; Raza A; Barcos M; Yousuf N; Saikia T; Masterson M; Bennett J; Browman G; Goldberg J; Grunwald H
    Leuk Res; 1991; 15(1):51-7. PubMed ID: 1900089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.